Cargando…
Case Report: Partial Response Following Nivolumab Plus Docetaxel in a Patient With EGFR Exon 20 Deletion/Insertion (p.N771delinsGF) Mutant Lung Adenocarcinoma Transdifferentiated From Squamous Cell Carcinoma
The histological transformation from lung squamous cell carcinoma (LUSC) to lung adenocarcinoma (LUAD) and p. N771delinsGF mutations in EGFR exon 20 (ex20) are exceedingly rare in non–small cell lung carcinoma (NSCLC). EGFR ex20 mutations are insensitive to EGFR tyrosine kinase inhibitors in NSCLC....
Autores principales: | Zhu, Lingling, Liu, Yanyang, Gao, Honglin, Liu, Jiewei, Zhou, Qinghua, Luo, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784849/ https://www.ncbi.nlm.nih.gov/pubmed/35083213 http://dx.doi.org/10.3389/fcell.2021.755135 |
Ejemplares similares
-
Case Report: Anlotinib Reverses Nivolumab Resistance in Advanced Primary Pulmonary Lymphoepithelioma-Like Carcinoma With FGFR3 Gene Amplification
por: Liu, Yanyang, et al.
Publicado: (2021) -
Charmonium production at FNAL/E771
por: Elia, V, et al.
Publicado: (1998) -
Efficient Synthesis of Potential Impurities in Levonadifloxacin
(WCK 771)
por: Kilbile, Jaydeo T., et al.
Publicado: (2021) -
771 Enzymatic Burn Wound Debridement: The Learning Curve
por: Mertz, Tamara, et al.
Publicado: (2023) -
Case Report: Osimertinib Followed by Osimertinib Plus Bevacizumab, Personalized Treatment Strategy for a Lung Cancer Patient With a Novel EGFR Exon 20 Insertion D770_N771insGT and Multiple Brain Metastases
por: Zhi, Xiaoyu, et al.
Publicado: (2021)